Multiple sclerosis (MS) risk is higher in children and adolescents with type 1 diabetes, according to research. Susanne Bechtold, M.D., a [...]
In a new study published in the journal Nature Communications, researchers at the University of Bristol claim that the diseases could be [...]
Inflammation in a brain region called the hippocampus might explain why patients with multiple sclerosis (MS) suffer from depression far [...]
1. Tysabri (Natalizumab) Natalizumab (manufactured by Biogen Idec as Tysabri; previously named Antegren) is a humanized monoclonal [...]
Multiple sclerosis patients’ personal circumstances largely shape their views on therapy preferences
Opinions voiced by multiple sclerosis (MS) patients as to what they most want from, and like in, an MS treatment differ widely, although [...]
An extension of the phase II BOLD study found sustained reductions in gadolinium-enhancing T1 and new or enlarging T2 lesions over 2 years [...]
The collective microenvironment of gut bacteria, called the gut microbiome, has come to receive attention in many research labs for its [...]
High blood pressure may be linked to greater overall disability in people with multiple sclerosis (MS), although the rate at which [...]
Individuals with genetically increased body mass indexes were at a greater risk for developing multiple sclerosis (MS), according to [...]
